A simple, robust flow cytometry-based whole blood assay for investigating sex differential interferon alpha production by plasmacytoid dendritic cells
Sampson O. et al, (2022), Journal of Immunological Methods, 504, 113263 - 113263
Divergent trajectories of antiviral memory after SARS-CoV-2 infection
Tomic A. et al, (2022), Nature Communications, 13
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern
Skelly DT. et al, (2021), Nature Communications, 12
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern.
Skelly DT. et al, (2021), Nature communications, 12
Phase I Trial Evaluating the Safety and Immunogenicity of Candidate TB Vaccine MVA85A, Delivered by Aerosol to Healthy M.tb-Infected Adults.
Riste M. et al, (2021), Vaccines, 9
A haemagglutination test for rapid detection of antibodies to SARS-CoV-2
Townsend A. et al, (2021), Nature Communications, 12
High prevalence of occult thrombosis in cases of mild/moderate COVID-19.
Chen B. et al, (2021), International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 104, 77 - 82
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
Peng Y. et al, (2020), Nature Immunology, 21, 1336 - 1345
Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study
Eyre DW. et al, (2020), eLife, 9
Clinical and epidemiological features of COVID-19 family clusters in Beijing, China
Song R. et al, (2020), Journal of Infection, 81, e26 - e30
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Folegatti PM. et al, (2020), The Lancet, 396, 467 - 478
Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial.
Fidler S. et al, (2020), Lancet (London, England), 395, 888 - 898
Self-Maintaining CD103+ Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses
Abd Hamid M. et al, (2020), Cancer Immunology Research, 8, 203 - 216
A Comprehensive Analysis of Key Immune Checkpoint Receptors on Tumor-Infiltrating T Cells From Multiple Types of Cancer
Li X. et al, (2019), Frontiers in Oncology, 9
Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8+ Tumor-Infiltrating T Lymphocyte Responses
Abd Hamid M. et al, (2019), Cancer Immunology Research, 7, 1293 - 1306
Virological remission after antiretroviral therapy interruption in female African HIV seroconverters
Gossez M. et al, (2019), AIDS, 33, 185 - 197
Clinical utility of existing and second-generation interferon-γ release assays for diagnostic evaluation of tuberculosis: an observational cohort study.
Whitworth HS. et al, (2019), Lancet Infect Dis
Measurement of Typhi Vi antibodies can be used to assess adaptive immunity in patients with immunodeficiency.
Evans C. et al, (2018), Clin Exp Immunol, 192, 292 - 301
Whole-genome sequencing identifies nosocomial transmission of extra-pulmonary M. tuberculosis—response
Walker TM. et al, (2017), QJM: An International Journal of Medicine, 110, 613 - 613